Comparison of Local Medicare Guidance and Medicare Advantage Plans for Stereotactic Radiosurgery for Brain Metastases
Despite general concordance, the added criteria by MAOs could impose more stringent requirements than CMS, potentially resulting in coverage denials. It is important that MAO policies remain consistent with evidence-based guidelines to avoid disparities that could impact patient treatments.
Authors
- Scott Floyd (ORCID: https://orcid.org/0000-0002-8067-2426)
- Dominic LaBella (ORCID: https://orcid.org/0000-0003-1713-9538)
- Trey C. Mullikin (ORCID: https://orcid.org/0000-0002-1099-1763)
- Zachary J. Reitman (ORCID: https://orcid.org/0000-0002-9122-9550)
- Paul W. Sperduto (ORCID: https://orcid.org/0000-0002-4628-7161)
- Eugene Vaios (ORCID: https://orcid.org/0000-0003-2122-6650)
- John P. Kirkpatrick (ORCID: https://orcid.org/0000-0002-4019-0350)
- Eileen Battershall
Institutions
- Duke Medical Center (US)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1016/j.adro.2025.101974
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00